| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |